Insider buying
~$6.3K574 sh @ $10.90
Traded Feb 10, 2025 · filed 17 days later
A major shareholder of Oruka Therapeutics paid $6.3K out of pocket for Oruka Therapeutics shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
3 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 18, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q3 2024 13F
477,327
583,327
+22.2%
Share count drives classification; reported value also moves with price
0.47%
Within the filing's reported positions, not the manager's total assets
3
For Q4 2024
Insider buying
Traded Feb 10, 2025 · filed 17 days later
A major shareholder of Oruka Therapeutics paid $6.3K out of pocket for Oruka Therapeutics shares.
Insider buying
Traded Feb 11, 2025 · filed 16 days later
A major shareholder of Oruka Therapeutics paid $105K out of pocket for Oruka Therapeutics shares.
Insider buying
Traded Feb 12, 2025 · filed 15 days later
A major shareholder of Oruka Therapeutics paid $106K out of pocket for Oruka Therapeutics shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.